Hoffmann, J., Knoop, C., Enk, A., & Hadaschik, E. (2018). Long persistence of tumour necrosis factor-α antagonist-induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: A case study of 14 patients with psoriasis. British journal of dermatology, 178(1), . https://doi.org/10.1111/bjd.15701
Chicago-Zitierstil (17. Ausg.)Hoffmann, Jochen, Christian Knoop, Alexander Enk, und Eva Hadaschik. "Long Persistence of Tumour Necrosis Factor-α Antagonist-induced Autoantibodies Under Subsequent Treatment with Ustekinumab but No Adverse Effects: A Case Study of 14 Patients with Psoriasis." British Journal of Dermatology 178, no. 1 (2018). https://doi.org/10.1111/bjd.15701.
MLA-Zitierstil (9. Ausg.)Hoffmann, Jochen, et al. "Long Persistence of Tumour Necrosis Factor-α Antagonist-induced Autoantibodies Under Subsequent Treatment with Ustekinumab but No Adverse Effects: A Case Study of 14 Patients with Psoriasis." British Journal of Dermatology, vol. 178, no. 1, 2018, https://doi.org/10.1111/bjd.15701.